326595-91-9

Upstream product

• 38464-75-4 4,4-diphenylcyclopent-2-en-1-one 
• 138951-96-9 5,5-diphenyl-2-cyclopenten-1-ol 
• 138951-99-2 2,2-diphenylpent-4-ynal 
• 138952-00-8 3-acetyl-2,2-diphenylpropionaldehyde 
• 21599-40-6 2,2-diphenyl-4-pentynenitrile 
• 86-29-3 Diphenylacetonitrile 
• 947-91-1 Diphenylacetaldehyde 

Downstream Products

• 138951-50-5 (R,S)-N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine 
• 138952-06-4 4,4-diphenyl-2-cyclopentenyl chloride 

Relevant academic research and scientific papers

Asymmetric synthesis and determination of the absolute configuration of FK584, an agent for the treatment of overactive detrusor

FK584[(-)-N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine hydrochloride, (-)-4·HCl], a potential candidate for the treatment of overactive detrusor, was synthesized in a 4-step approach starting with Sharpless oxidation of cyclopentenol 6 (kinetic resoluti

Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2- cyclopentenylamine

N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi

Substituted-amine compound and a process for the preparation thereof

The compound (-)-N-t-butyl-4,4-diphenyl-2-cyclopentenylamine, or its hydrochloride salt has anticholinergic activity, and thus has a variety of pharmaceutical utilities.